-
admin
Posts
Thousand-Year Grand Canal Revitalized in China’s Cangzhou after 10 years’ recognition of UNESCO World Heritage
CANGZHOU, China, June 25, 2024 /PRNewswire/ — The year 2024 marked the 10th anniversary of Grand Canal’s UNESCO world heritage listing. The success of the...
NABR Commends the IUCN’s Decision to Reassess the Status of Long-Tailed Macaques
A Science-Based Approach Will Determine if the Species is Truly ‘Endangered’ WASHINGTON, June 25, 2024 /PRNewswire/ — The National Association for Biomedical Research (NABR) commends...
Auden Launches New Solution at ComNext 2024 for Adopting 5G NTN in Private Networks
Addressing the signal range challenge of many Beyond 5G networks, antenna and low-earth orbit satellite expert is facilitating adoption of 5G NTN in smaller private...
Emphasys Achieves Gold Partnership with Informatica, Enhancing Data Solutions
SYDNEY, June 25, 2024 /PRNewswire/ — Emphasys Pty Ltd, a pioneer in SAP services and solutions, proudly announces its newly awarded Gold Partnership with Informatica,...
“Exchanging Trash for Dreams”: China UnionPay leverages art show to promote ecological preservation for China’s “water tower”
China UnionPay CHENGDU, China, June 24, 2024 (GLOBE NEWSWIRE) — On June 5, an art exhibition titled “Exchanging Trash for Dreams” opened in Harvest Moon Art...
Poland Ecommerce Market Report 2024, Featuring bonprix, Terg’s Media Expert, Zalando, zooplus, Bolt Food, Glovo, Pyszne, Too Good To Go, Uber Eats, iTaxi, mytaxi, Rainbow Tours and Travelplanet
Dublin, June 24, 2024 (GLOBE NEWSWIRE) — The “Poland Ecommerce Market Opportunities Databook – 100+ KPIs on Ecommerce Verticals (Shopping, Travel, Food Service, Media &...
InflaRx’s GOHIBIC (Vilobelimab) Selected for First BARDA-Sponsored Clinical Trial to Evaluate Novel Host-Directed Therapeutics for Acute Respiratory Distress Syndrome (ARDS)
JENA, Germany, June 24, 2024 (GLOBE NEWSWIRE) — InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, announced today...
Helsinn Group announces AKYNZEO® (fosnetupitant/palonosetron) injection is now available in a ready-to-use vial in the US
Helsinn Group announces AKYNZEO® (fosnetupitant/palonosetron) injection is now available in a ready-to-use vial in the US Lugano, Switzerland – June 24, 2024 – Helsinn Group...
Kiniksa Pharmaceuticals Partners with NHL Hall-of-Famer Henrik Lundqvist to Raise Awareness of Recurrent Pericarditis
– Campaign to elevate experiences from the recurrent pericarditis community and provide resources to patients and caregivers – HAMILTON, Bermuda, June 24, 2024 (GLOBE NEWSWIRE)...
Rezolute Announces Closing of Public Offering with Approximately $60M in Gross Proceeds
NEW YORK, June 24, 2024 (GLOBE NEWSWIRE) — Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage biopharmaceutical company committed to developing novel, transformative therapies...
